How Accurate MIC Results Can Help Manage Critical Patients with MDRO Infections

Understanding the Critical Role of the Microbiology Lab

The microbiology laboratory plays a critical role in the acute management of patients with multidrug-resistant organism (MDRO) infections, including those involving new-generation antimicrobials. The selection of the right method to determine antimicrobial susceptibility and specifically the minimum inhibitory concentration (MIC) is crucial.

It is of particular significance in determining the appropriate treatment for critically ill patients with severe infections. Delayed or inaccurate results can lead to the mistreatment of, complications with, and the potential mortality of patients with MDRO infections.

In this webinar, we will review three challenging cases that illustrate the role the microbiology lab plays in the management of critically ill patients. The knowledge of and capacity to test new antimicrobial agents can significantly impact patient outcomes when dealing with MDRO infections.  

Learning Objectives

This webinar will help you:

• Restate the importance of correct antibiotic selection for critically ill patients and the risk of poor outcomes
• Discuss the utility of multiple data sources, including antibiograms and combination antibiograms in the selection of effective treatment options
• Describe how new-generation therapeutics and accurate MIC results can help manage critical patients.
• Explain the importance of accurate results and breakpoints when treating critically ill patients

Watch on Demand       Download Slides (PDF, 2.8MB)

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.

James A. McKinnell, MD

Dr. James A. McKinnell is an associate professor of medicine at the David Geffen School of Medicine at the University of California, Los Angeles. He is a member of the Infectious Disease Clinical Outcome Research Unit (ID-CORE) and the Los Angeles Biomedical Research Institute at Harbor-UCLA. A nationally recognized infectious disease specialist with research interests in the clinical management and prevention of nosocomial infections, Dr. McKinnell has published over 40 papers about antibiotics and antimicrobial resistance in the community.